Multimodal Data | Caris Life Sciences
Home / Biopharma / Multimodal Data

Multimodal Data

Caris Life Sciences is at the forefront of a data-led revolution in personalized cancer care. In partnership with biopharma innovators, Caris is shaping the future of precision oncology by developing groundbreaking solutions that deliver powerful outcomes. By combining advanced molecular science and artificial intelligence (AI) with years of experience and a world-class database comprised of both whole exome and whole transcriptome sequencing, Caris generates actionable insights to help accelerate the development of new medicines and diagnostics.

Caris is the industry leader when it comes to case volume combined with breadth and depth of multimodal data – the combination of molecular, claims, and real-world data:

  • Molecular data spanning more than 550,000 matched clinico-genomic profiles and across 57 indications
  • Real-world claims data through partnerships to enable the ability to see deeper into patient journey than ever before
  • H&E Images, Digital Pathology
  • Algorithm and Signature development

DNA/RNA landscaping

WES & WTS

Mapping the tumor microenvironment (TME)

Repository of unstained FFPE slides

Connecting biology to clinical care

  • 550K+ matched genomic profiles with claims data
  • Deeply curated EHR through multiple clinical linkages

Identify ideal patient populations

Caris has developed one of the world’s largest clinico-genomic databases, comprising more than half a million patients’ genomic profiles, most with matched clinical outcomes and digital pathology, and covering a broad spectrum of tumor types. 

Caris has developed advanced machine learning and artificial intelligence tools to help physicians and researcher navigate data-dense genomic information to create clinically meaningful solutions in ways never before possible.

Caris’ comprehensive molecular profiling portfolio is designed to reveal a molecular blueprint that can guide more precise and individualized treatment decisions to help improve patient outcomes.

The fundamental understanding of disease at the molecular level is the essence of precision medicine.

Unlock truly novel and otherwise inaccessible targets for your discovery pipeline with Caris Discovery.

Partner with Biopharma

"*" indicates required fields

Name*
Location*
Preferred contact method*
Best time to contact
: